standard-title
Alzheimer’s Disease
Latest News Regarding Alzheimer’s Disease and Your Health
Loading…
Biogen, a multinational biotechnology company, and Eisai, a Japanese pharmaceutical company, are planning to file for Food and Drug Administration (FDA) approval for an Alzheimer’s drug that had mixed results in clinical trials. Can this controversial medication offer fresh hope to millions of people worldwide? A multinational biotech company will push for the regulation of a new Alzheimer’s drug that has met with some controversy. Across the world, around 50 million people live with dementia, the most common form of which is Alzheimer’s disease. Researchers are continually developing and testing new drugs to try and slow down, reverse, or at least improve the symptoms of this currently incurable condition. Yet many new drugs that scientists develop never make it beyond the clinical trial stage, as they either cause too many side effects or prove much less effective than their creators had hoped. And then there are some drugs that bring about mixed results when tested in clinical trials. One such drug is aducanumab, which was developed by scientists affiliated with Biogen, a multinational biotechnology company headquartered in Cambridge, MA. Aducanumab is a monoclonal antibody that is supposed to prevent or slow down neurodegeneration by removing toxic beta-amyloid plaques from the […]
As interest in gut bacteria peaks, they are implicated in yet another condition. Researchers recently identified stark differences in levels of specific gut bacteria in people with dementia. A new study links changes in gut bacteria to dementia. Our bodies swarm with microscopic visitors. On our skin, in our mouths, deep in our lungs, and, of course, nestled in our digestive systems. The bacteria in the gut have long been known to assist the digestive process, but in recent years, it has become clear that they are involved in much, much more. With bacteria now implicated in conditions as diverse as diabetes and schizophrenia, we truly are in the age of the microbiome. Recently, researchers in Japan investigated whether gut bacteria might, one day, help in the diagnosis and even treatment of dementia. Dr. Naoki Saji, from the Center for Comprehensive Care and Research on Memory Disorders at the National Center for Geriatrics and Gerontology in Obu, Japan, led the team of scientists. The researchers will present their findings at the American Stroke Association’s International Stroke Conference 2019 in Honolulu, HI. Examining feces The researchers recruited 128 participants from their memory clinic. The average age was 74.2, and 59 percent […]
By Deborah DiSesa HirschHealthDay Reporter Latest Alzheimer’s News TUESDAY, Oct. 29, 2019 (HealthDay News) — Unpaid bills, overdrawn accounts, dwindling investments: When seniors begin experiencing fiscal troubles, early dementia or Alzheimer’s disease could be an underlying cause, researchers say. In the early stages of the disease, people with undiagnosed Alzheimer’s are at high risk of making foolish and dangerous decisions about their finances, mostly because families may not know they need help, researchers say. “Individuals often aren’t diagnosed early enough, and it’s a perfect storm,” said study author Carole Gresenz, a professor of health systems administration at Georgetown University in Washington, D.C. “They’re vulnerable to large reductions in liquid assets because they’re not making wise decisions about their finances, savings and checking accounts. This can also reduce net wealth,” added Gresenz. Ruth Drew, director of information and support services for the Alzheimer’s Association, pointed out that Alzheimer’s destroys the brain. “As the disease progresses, everyone with Alzheimer’s will reach a point where they need help with their finances and ultimately assistance with daily tasks and around-the-clock care. We have certainly spoken to people whose finances were significantly affected,” she said. In some cases, people responsible for making major financial decisions, […]
Researchers reveal a marker and new testing tool of frontotemporal dementia that may help distinguish this condition from Alzheimer’s disease. ‘Moral emotions’ are ones that prompt us to do good and contribute to pro-social behavior and cooperation. Frontotemporal dementia (FTD) is a less common form of dementia than Alzheimer’s. Sometimes called Pick’s disease or frontal lobe dementia, this condition occurs when brain cells in the frontal or temporal lobes of the brain, or both, become damaged. The frontal lobes of a person’s brain are responsible for problem-solving, planning, emotional control, and behavior. FTD may also affect the temporal lobes, which can be found on each side of the brain and deal with speech, the meaning of words, and recognition of faces or objects. In addition to difficulties with language, FTD also causes changes in personality and behavior. For instance, people with FTD may experience mood changes that do not normally characterize them. They may act more impulsively, lose their social inhibitions, feel apathetic, or lose interest in the emotions of other people or in socializing. Although some of these symptoms are similar to other, more common forms of dementia, such as Alzheimer’s disease, FTD is different from Alzheimer’s. In an […]
A global study on attitudes toward dementia has shown that two-thirds of people believe it to be a natural risk of getting older, which could be limiting the help that people seek. The vast majority of people believe that they will develop dementia and that they can do little about it, new research finds. Every 3 seconds, someone develops dementia somewhere in the world. In the United States alone, 5.8 million people are living with Alzheimer’s, and every 65 seconds, another person develops the disease. Alzheimer’s is the sixth leading cause of death in the U.S., beating breast and prostate cancer together, and it is one of the world’s fastest growing causes of death. According to Alzheimer’s Disease International (ADI), the number of people living with dementia is likely to triple from the current 50 million to 152 million by 2050. Despite the prevalence of this neurodegenerative disorder, the world’s largest survey of attitudes toward it has shown that there is very little true understanding across the globe, even among healthcare professionals. The study, which surveyed 70,000 people in 155 countries, found that 62% of healthcare professionals also believe that dementia is a normal part of aging. The findings also […]
Neurodegenerative diseases, such as Alzheimer’s and Huntington’s, share a mechanism of brain cell damage that could offer a new target for treatment, according to new research in human cells and mice. A newly discovered mechanism of brain cell damage could hold the key to treating several neurodegenerative conditions. A recent Nature Neuroscience study describes how researchers uncovered the mechanism and how it leads to death of neurons, or nerve cells. “We’ve identified a potential new way to reduce nerve cell death in a number of diseases characterized by such losses,” says senior study author Daria Mochly-Rosen, Ph.D., a professor of chemical and systems biology at Stanford University School of Medicine, in California. The mechanism involves microglia and astrocytes, two types of cell that normally help to protect neurons, or nerve cells. Microglia and astrocytes are glial cells, a type of cell that scientists once regarded as the “glue of the nervous system.” That is no longer the case, however, as researchers are increasingly discovering that glial cells play vital roles in brain development and function. Among the many jobs that astrocytes fulfill is to determine the number and locations of the connections that neurons make with each other. These glial […]
Despite decades of research, Alzheimer’s disease still holds many mysteries. A recent study asks whether spontaneous changes to the chemistry of proteins might help explain the neurological hallmarks of Alzheimer’s. A new study looks at the chemistry of Alzheimer’s-related proteins. Alzheimer’s disease is the most common form of dementia; it currently affects an estimated 5.5 million people in the United States. As it stands, there is no cure, and researchers are still trying to come to grips with what makes Alzheimer’s tick. The main focus of medical research has been plaques and tangles, the protein-based markers of the Alzheimer’s brain. A recent paper, published in ACS Central Science, asks whether these features might occur due to what they refer to as “spontaneous chemistry.” Plaques and tangles Plaques consist of a protein called beta-amyloid. Usually, this protein is cleared away by cells, but in the Alzheimer’s brain, it sticks together in clumps between nerve cells. A protein called tau forms neurofibrillary tangles, which develop inside brain cells. Tau is associated with microtubules, which are long, thin, tubular structures that provide support to the cell. In Alzheimer’s, tau is altered, and microtubules cannot form correctly; instead, they form twisted filaments. Despite a […]
Latest Alzheimer’s News WEDNESDAY, March 27, 2019 (HealthDay News) — A dementia study has led researchers to a brain region that processes spoken, not written, words. Northwestern University researchers worked with four patients who had a rare type of dementia called primary progressive aphasia (PPA), which destroys language. Although able to hear and speak, they could not understand what was said out loud. However, they could still process written words. For example, if they read the word “hippopotamus,” they could identify a picture of a hippo. But if someone said the word “hippopotamus,” they couldn’t point to its picture. Through their tests with these patients, the researchers were able to identify an area in the left brain that appears specialized to process spoken words. “We always think of these degenerative diseases as causing widespread impairment, but in early stages, we’re learning that neurodegenerative disease can be selective with which areas of the brain it attacks,” said senior author Sandra Weintraub. She’s a professor of psychiatry and behavioral sciences and neurology at Northwestern’s Feinberg School of Medicine in Chicago. “The fact that only the auditory words were impaired in these patients and their visual words were untouched leads us to believe […]
Dementia refers to a series of neurodegenerative diseases, such as Alzheimer’s, where a person’s memory and other cognitive abilities decline. A recent study may have found a new risk factor that might predispose people to dementia: lung disease. To limit the risk of dementia, people may also want to look after the health of their lungs, a new study suggests. According to the study by researchers from the University of Minnesota’s School of Public Health in Minneapolis in collaboration with colleagues from other academic institutions in the United States, people who experience lung disease in midlife may have an increased risk of dementia later on. The study’s findings appear in the American Journal of Respiratory and Critical Care Medicine, a journal of the American Thoracic Society. The research indicates associations between both restrictive and obstructive lung diseases and dementia or cognitive impairment risk. Doctors use the term restrictive lung diseases when the lungs are unable to expand. Such diseases include idiopathic pulmonary fibrosis, in which the lungs present scarring, and sarcoidosis, where some lung tissue becomes abnormally swollen. In obstructive lung diseases, something obstructs the air flow in or out of the lungs. The most common type of obstructive lung […]
Latest Alzheimer’s News THURSDAY, May 16, 2019 (HealthDay News) — Mornings spent figuring out Sudoku or finessing a crossword could spell better health for aging brains, researchers say. In a study of over 19,000 British adults aged 50 and over who were tracked for 25 years, the habit of doing word or number puzzles seemed to help keep minds nimble over time. “We’ve found that the more regularly people engage with puzzles such as crosswords and Sudoku, the sharper their performance is across a range of tasks assessing memory, attention and reasoning,” said research leader Dr. Anne Corbett, of the University of Exeter Medical School. “The improvements are particularly clear in the speed and accuracy of their performance,” she added in a university news release. “In some areas, the improvement was quite dramatic — on measures of problem-solving, people who regularly do these puzzles performed equivalent to an average of eight years younger compared to those who don’t.” Does that translate to protection against Alzheimer’s and other forms of dementia? The study “can’t say” at this point, Corbett said, “but this research supports previous findings that indicate regular use of word and number puzzles helps keep our brains working better […]
A recent study suggests that a warning sign may come before any symptoms of Alzheimer’s disease: Adults who do not get enough deep sleep may be on their way to developing the disease. A lack of deep sleep may lead to Alzheimer’s disease. Researchers from the Washington University School of Medicine in St. Louis, MO, found that older people who experience less slow-wave sleep (in other words, deep sleep) have elevated levels of a brain protein called tau. The findings, published in Translational Medicine, note that higher levels of tau are a sign of Alzheimer’s disease. Elevated levels have also previously been associated with both brain damage and cognitive decline. Slow-wave sleep and brain proteins Slow-wave sleep helps people consolidate their memories and experiences, and getting enough of this type of sleep helps people wake up refreshed and energized. In order to find out if there is a connection between a lack of deep sleep and the development of Alzheimer’s, the authors put together a study that involved 119 people aged 60 years or older. A full 80 percent of the participants had no cognition problems, and the rest had only mild impairment. To conduct the study, researchers monitored their […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News MONDAY, Aug. 5, 2019 (HealthDay News) — The evidence continues to mount that staying socially engaged as you age helps keep dementia at bay. In a new study, British researchers found that being socially active in your 50s and 60s may reduce the risk of developing dementia. The findings showed that people in their 60s who interacted with friends nearly every day had a 12% lower risk of developing dementia than people who saw a couple of friends every few months. “This has important implications for people in middle-age as it suggests that keeping socially active is important for brain health. We know that it has other health benefits in terms of benefiting physical and mental health,” said lead researcher Andrew Sommerlad, a research fellow in the division of psychiatry at University College London. Social activity during midlife was linked with better memory and reasoning skills, he said. “We think this may be because social contact gives us a chance to exercise different aspects of thinking, like memory and language, which may make people more resilient against the damage which accumulates in the brain in people who develop dementia,” Sommerlad explained. For the […]
By Len CanterHealthDay Reporter Latest Alzheimer’s News FRIDAY, Oct. 4, 2019 (HealthDay News) — When you hear the word diet, you might think only of weight loss. But a lifestyle diet can bring even greater benefits. One option that belongs on your radar is the MIND diet created by researchers at Rush University in Chicago. MIND stands for Mediterranean-DASH Intervention for Neurodegenerative Delay. It’s a hybrid of those two heart-healthy diets, both of which reduce the risk of high blood pressure, diabetes, heart attack and stroke. In initial studies, the MIND diet offered a huge additional benefit — lowering the risk of Alzheimer’s disease by up to 53% in participants who stuck to it rigorously and by about 35% in those who only did so moderately well. But the key is to start now, no matter your age, because it seems like the longer you follow it, the lower your risk of developing Alzheimer’s. Do Eat: Green leafy vegetables and other vegetables Nuts Blueberries or strawberries Beans Whole grains Fish Poultry Olive oil Wine Do Limit: Red meat Butter and stick margarine to less than a tablespoon a day Cheese, pastries, sweets, fried or fast food to one serving in […]
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
For the first time, researchers have identified two clusters of genes that appear to generate the neurological hallmarks of dementia. The discovery provides a new path toward drug discovery. Understanding the genetic mechanisms behind Alzheimer’s moves us ever closer to an effective treatment. Dementia is a growing concern throughout the Western world and beyond. According to the Alzheimer’s Association, around 5.7 million adults in the United States are living with Alzheimer’s, the most common form of dementia. By 2050, that figure is expected to rise to about 14 million. As the average lifespan extends, so does the reach of dementia. Currently, there is no cure for dementia and no way to slow its progress. Although many questions about dementia remain unanswered, our understanding is steadily growing. For instance, we know that a protein called tau plays an important role in a number of dementia types. Tau and dementia In healthy nerve cells, tau helps stabilize microtubules — the scaffolding that helps maintain the structure and rigidity of cells. In dementia, however, tau becomes hyperphosphorylated and clumps together in so-called neurofibrillary tangles. Scientists think that when tau is tangled, it damages nerve cells in at least two ways. Firstly, it can […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News SUNDAY, May 5, 2019 (HealthDay News) — When men with prostate cancer have to take drugs that block the testosterone fueling their tumors, they can suffer a host of side effects that include impotence, bone loss, heart trouble and obesity. But new research uncovers yet another possible downside to the treatment: These men may be at greater risk for dementia. For any type of dementia, that risk increased 17%; for Alzheimer’s disease, it increased 23%, the researchers said. Common side effects of so-called androgen-deprivation therapy include hot flashes, unstable mood, trouble sleeping, headaches, high blood sugar, allergic reactions and impotence. “Androgen-deprivation therapy may not only cause physical changes — such as osteoporosis, cardiovascular disease or obesity — but may also cause changes in cognition,” said researcher Dr. Karl Tully, a research fellow at Brigham and Women’s Hospital in Boston. But Tully cautioned that this study cannot prove that such hormone therapy caused dementia, only that the two are associated. The investigators also found that men on this type of therapy had a 10% greater risk of seeking psychiatric services. The risk for dementia increased as the length of therapy increased, the researchers noted. […]
People with a diagnosis of dementia can also face depression. For this reason, they may end up taking antidepressant drugs. Now, a study has found that these drugs may be able to treat not just depression, but dementia itself. A new study tests out the potential of antidepressants to tackle dementia mechanisms in the brain. According to data cited by the Alzheimer’s Association, 1 in 10 people aged 65 and over has Alzheimer’s disease, a form of dementia, characterized chiefly by memory loss, disorientation, and having trouble with normal daily activities. Moreover, people with Alzheimer’s can often also develop mental health issues, especially depression. For this reason, healthcare professionals may prescribe selective serotonin reuptake inhibitors (SSRIs) — a class of antidepressants — to individuals with dementia. Recently, researchers from the University of Waterloo in Ontario, Canada, have found a surprising mechanism at play, namely that SSRIs appear to inhibit the growth of dementia-specific aggregates in the brain. “These are promising findings for people with Alzheimer’s who are on SSRIs,” notes Prof. Praveen Nekkar Rao, one of the current study’s authors. “These finding may not only highlight benefits for people with depression and Alzheimer’s but can also provide insights to serve […]
Alzheimer’s disease is a form of neurocognitive decline that affects millions across the world. The exact cause is unclear, but new research is uncovering the mechanisms that allow Alzheimer’s to become established in the brain. Which brain cells are the most vulnerable to Alzheimer’s? In Alzheimer’s disease, as in other forms of dementia, a defining feature is the accumulation of certain toxic proteins in the brain. These proteins aggregate into plaques that disrupt the communication between brain cells, thus enhancing cognitive problems and other issues. More often than not, researchers identify the protein beta-amyloid as the main culprit in this disruptive process. However, another protein, called tau, is just as important. In a new study, researchers from a series of academic institutions, including the Ohio State University in Columbus, Columbia University Medical Center in New York, NY, and Cambridge University in the United Kingdom, have found that tau accumulates preferentially around a specific type of brain cell. The investigators also revealed that certain genetic profiles may predispose a person to tau aggregations around those cells. Co-lead author of the study Hongjun (Harry) Fu — now an assistant professor in the Department of Neuroscience at Ohio State University — and colleagues […]
New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. This knowledge, however, also indicates a potential preventive strategy, researchers show. An irregular heartbeat speeds up the rate at which cognitive function deteriorates, but there may be an easy way to address this. In a new study paper published yesterday in the journal Neurology, researchers at the Karolinska Institute and Stockholm University, which are in Sweden, explain that atrial fibrillation (A-fib) is linked with an increased risk of developing dementia. In A-fib, the heart’s atria — or the chambers that receive blood and then send it to the ventricles, which pump it out to the rest of the body — beat irregularly. Because of this, blood can pool inside the heart and form clots, which may later circulate to the brain, leading to a stroke. The new study has found that A-fib also increases the risk of another health problem as people age — namely, dementia. However, this warning also comes with an encouraging solution, the authors explain. “Compromised blood flow caused by atrial fibrillation may affect the brain in a number of ways,” as study co-author Chengxuan […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — One of the hallmarks of Alzheimer’s is the accumulation of beta-amyloid plaques in the brain, but what part those plaques play in the development of the disease isn’t clear. Now researchers have taken the first steps to trace the progression of plaque buildup in living patients. This way of “staging” the disease has implications for research and one day may help doctors treat this debilitating, fatal disease. “It is possible to stage individuals in terms of how advanced their beta-amyloid deposition is, using PET scans,” said lead researcher Dr. Niklas Mattsson, an associate professor of clinical neuroscience at Lund University in Sweden. When beta-amyloid appears, it follows certain stages, he explained. Some brain regions are involved early, others at the intermediate stage, and some in the late stage of Alzheimer’s. “These stages are also associated with other hallmarks of Alzheimer’s disease, such as levels of tau [another type of protein] in cerebral spinal fluid, cognitive decline and the wasting away of brain cells,” Mattsson added. “This staging system can be used both to improve research and perhaps also in clinical trials, to see if certain drugs […]
There is no doubt that smoking damages health and increases the risk of many diseases and premature death. However, a study that followed hundreds of older adults for more than 10 years found no link between tobacco smoking and raised dementia risk. A new study suggests there is no causal link between smoking and the risk of developing dementia. Dementia is the general name for conditions that diminish the capacity to think, remember, reason, and interact with others. These symptoms can progress to the point that people are no longer able to carry out their daily activities and take care of themselves. The recent finding contradicts many earlier studies that have tied smoking to higher risk of dementia. This could be because, for the new investigation, researchers from the University of Kentucky in Lexington analyzed the data in a different way. They used a statistical method called “competing risk analysis” to allow for the strong effect that smoking has on risk of death. In a paper that now features in the Journal of Alzheimer’s Disease, first study author Erin L. Abner Ph.D., an associate professor in the university’s Sanders-Brown Center on Aging, and her colleagues describe their approach and findings. […]
A protein that plays a key role in early neural development is also essential for learning and memory in the adult brain. A protein called netrin may boost learning and memory by strengthening neural connections in the adult brain. The protein, called netrin, strengthens connections between brain cells. This is according to recent research led by the Montreal Neurological Institute and Hospital (The Neuro), a teaching and research institute of McGill University in Canada. Scientists already knew that netrin is essential for the development of the embryonic and infant brain, where it helps make connections between brain cells, or neurons. The recent research reveals that the protein also strengthens those neural connections, or synapses, in the adult brain’s hippocampus, an area that is involved in memory and learning. The journal Cell Reports recently published a paper on the study, which the team conducted on cells from developing and adult rat brains. “It was a mystery,” comments senior study author Dr. Timothy E. Kennedy, who runs a research laboratory at The Neuro, “why neurons would continue making netrin in the adult brain after all the connections had already been made in infancy.” Molecule key for synapse strengthening According to Dr. Kennedy, […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News THURSDAY, Oct. 17, 2019 (HealthDay News) — Could your personality as a teen forecast your risk for dementia a half-century later? Very possibly, say researchers, who found that dementia risk is lower among seniors who were calm, mature and energetic high schoolers. “Being calm and mature as teen were each associated with roughly a 10% reduction in adult dementia risk,” said study co-author Kelly Peters, principal researcher at the American Institutes for Research in Washington, D.C. “And vigor was associated with a 7% reduction.” The finding has its origins in the 1960s, when more than 82,000 students in roughly 1,200 U.S. high schools took a personality test. More than 50 years later, their personality traits were compared to dementia diagnoses. While Peters said there’s plenty of evidence that personality changes near the time of a dementia diagnosis, the lingering question has been whether personality or some aspects of it actually causes dementia. “That’s the big question,” she said. “Is it only that personality can be affected by dementia? Is it just an expression of the disease?” By focusing on teens who didn’t later develop dementia, Peters said, “this study really starts to tease […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Dec. 20, 2018 (HealthDay News) — Walking and other types of moderate exercise may help turn back the clock for older adults who are losing their mental sharpness, a new clinical trial finds. The study focused on older adults who had milder problems with memory and thinking skills. The researchers found that six months of moderate exercise — walking or pedaling a stationary bike — turned some of those issues around. Specifically, exercisers saw improvements in their executive function — the brain’s ability to pay attention, regulate behavior, get organized and achieve goals. And those who also made some healthy diet changes, including eating more fruits and vegetables, showed somewhat bigger gains. The effect was equivalent to shaving about nine years from their brain age, said lead researcher James Blumenthal, a professor at Duke University School of Medicine, in Durham, N.C. In contrast, those same mental abilities kept declining among study participants who received health education only. Experts said the findings support the general concept that a healthy lifestyle can help protect the brain as you age. “And it’s never too late to start,” said Keith Fargo, director of scientific programs and […]
Latest Alzheimer’s News WEDNESDAY, Oct. 30, 2019 (HealthDay News) — Nearly 13 million Americans will have dementia by 2040 — nearly twice as many as today, a new report says. The number of women with dementia is expected to rise from 4.7 million next year to 8.5 million in 2040. The number of men with dementia is projected to increase from 2.6 million to 4.5 million. Over the next 20 years, the economic impact of Alzheimer’s disease and other forms of dementia will be more than $2 trillion. Women will shoulder more than 80% of those costs, according to a report released Tuesday at the 2019 Milken Institute Future of Health Summit, in Washington, D.C. “Longer life spans are perhaps one of the greatest success stories of our modern public health system,” said lead author Nora Super, senior director of the Milken Institute Center for the Future of Aging. “But along with this success comes one of our greatest challenges,” she added in an institute news release. “Our risk of developing dementia doubles every five years after we turn 65; by age 85, nearly one in three of us will have the disease.” With no cure on the horizon, reducing […]
Researchers are growing increasingly interested in the relationship between blood pressure and dementia. The most recent study investigates how patterns of change in blood pressure over the decades might influence risk. What can blood pressure fluctuations tell us about dementia risk? As the United States population ages, dementia incidence rises in tandem. Today, around 5 million people in the U.S. have a dementia diagnosis. Studies published over the last few years have produced evidence that hypertension (high blood pressure) during midlife appears to increase the risk of dementia and cognitive decline. Hypertension affects an estimated 1 in 3 adults in the U.S., so it is vital to understandi the exact relationship between blood pressure and the aging brain. Researchers have done less work to investigate the links between blood pressure during later life and cognitive outcomes. However, as the authors of a recent study explain, the findings hint that “optimal blood pressure ranges for older adults may depend on earlier blood pressure characteristics.” In other words, the impact of hypertension on the aging brain may depend on the pattern of blood pressure from midlife onward. Blood pressure changes through life The authors of the current study, published in JAMA Network, […]
An Alzheimer’s diagnosis often relies on signs of memory problems. However, these issues usually do not appear until years after the disease has taken hold. A new smartphone game is using spatial navigation to detect Alzheimer’s before it is too late. A simple game that people can play on their smartphones could help detect Alzheimer’s risk. Another person develops Alzheimer’s disease every 3 seconds, according to Alzheimer’s Disease International. The number of people living with this most common form of dementia currently stands at around 50 million. By 2050, experts expect this figure to have tripled. The last “significant breakthrough” in Alzheimer’s research happened 4 decades ago, states the latest World Alzheimer’s Report. However, a recently developed smartphone game may alter that statistic. “Research shows us that the brain changes associated with diseases like Alzheimer’s begin decades before symptoms like memory loss start,” says Hilary Evans, chief executive at Alzheimer’s Research United Kingdom. “[F]or future Alzheimer’s treatments to be effective, it’s likely they must be given at the earliest stages of disease, before there’s too much damage to the brain.” Navigating space A collaboration between the organization, the University of East Anglia (UEA) and University College London in the U.K., […]
Latest Alzheimer’s News THURSDAY, Sept. 19, 2019 (HealthDay News) — For people at risk of Alzheimer’s disease, working out a couple of times a week might at least slow the onset of the illness, new research suggests. Regular exercise over a year slowed the degeneration of the part of the brain tied to memory among people who had a buildup of amyloid beta protein in their brain. These protein “plaques” are a hallmark of Alzheimer’s, noted researchers at the University of Texas Southwestern Medical Center in Dallas. Aerobic exercise didn’t stop plaques from spreading, but it might slow down the effects of amyloid on the brain, especially if started at an early stage, the research team suggested. “What are you supposed to do if you have amyloid clumping together in the brain? Right now doctors can’t prescribe anything,” lead researcher Dr. Rong Zhang said in a university news release. However, “if these findings can be replicated in a larger trial, then maybe one day doctors will be telling high-risk patients to start an exercise plan,” he said. “In fact, there’s no harm in doing so now.” One expert who wasn’t involved in the study agreed with that advice. “Exercise is […]
An international working group of experts has agreed on guidelines to help increase scientific and public awareness about a brain condition that mimics Alzheimer’s disease. The condition is not new but has come to light in recent research and clinical trials. Researchers have identified a misfolded protein in the brain that may be ‘a possible Alzheimer’s mimic.’ Scientists have recently recognized Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) as a “newly named pathway to dementia.” The working group consists of scientists from a number of centers that receive support from the National Institutes of Health (NIH), together with colleagues from other countries. The experts suggest that the public health impact of LATE on people in their mid-80s and older is probably about the same, if not bigger, than that of Alzheimer’s disease. In a report that now features in the journal Brain, the group proposes the first definition of LATE and recommends guidelines for those who are concerned with diagnosis and furthering research. Richard J. Hodes, M.D., who is director of the National Institute on Aging (NIA), which forms part of the NIH, says that even though researchers working on Alzheimer’s disease are making progress, they still ask themselves: “When is Alzheimer’s […]
The first large-scale cohort study of its kind looked at the link between waist circumference in later life and the risk of dementia in a population of older Asian adults. Share on PinterestCould waist size predict dementia risk in older adults? Physicians, healthcare professionals, and medical researchers tend to use body mass index (BMI) to determine if a person’s weight is too high, too low, or “normal.” Despite its widespread use, BMI has its flaws — and one flaw is the fact that it does not discern between fat (adipose tissue) and muscle content (lean tissue). For this reason, some scientists have suggested that waist-to-height ratio or waist circumference measurements may be more accurate indicators of a person’s healthy weight. When it comes to older age, however, is there any link between waist circumference and cognitive health? One 2019 study that Medical News Today reported on, for example, found a link between carrying excess weight around the stomach and experiencing brain atrophy, or brain shrinkage. Another large study, this time from 2018, found correlations between belly fat and poorer cognitive function. However, some of these studies looked at BMI or waist-to-hip ratio. Others have found that a higher BMI raises […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News FRIDAY, Nov. 15, 2019 (HealthDay News) — Many Americans believe they are likely to develop dementia — and they often turn to unproven ways to try to better their odds, a new study suggests. In a survey, researchers found that almost half of Americans in their 50s and 60s believed they were at least “somewhat likely” to develop dementia. Yet few — 5% — said they had talked to their doctor about ways to lower their risk. Instead, one-third or more were taking fish oil, vitamin E or other supplements to help ward off memory decline — even though none have been proven to have such benefits. “It certainly seems like people believe that supplements or fish oil help preserve their memory,” said lead researcher Dr. Donovan Maust, a geriatric psychiatrist at the University of Michigan, in Ann Arbor. Maust said that might reflect “excitement” over initial research suggesting that certain supplements might ward off memory decline — excitement that wasn’t tempered when later studies failed to show benefits. The findings, published online Nov. 15 in JAMA Neurology, are based on 1,019 adults aged 50 to 64 who were surveyed in 2018. They […]
Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer’s disease. Currently, there is no way to halt its progress, but clinical trials of new drugs are underway. What approach will serve specialists best? A new review of clinical trials advises on the best way forward. According to the World Health Organization (WHO), approximately 50 million people around the world live with dementia, and approximately 60–70 percent have Alzheimer’s disease. The greatest risk factor for Alzheimer’s disease is aging, and people ages 65 or older are the most vulnerable. Current treatments for this condition address its symptoms, such as memory loss and behavioral changes. However, more and more research aims to find a therapy that will tackle the biological changes that characterize Alzheimer’s disease. But are researchers on the right track with their investigations, and what would be the best treatment approach? A new comprehensive review published in the journal Neurology, and available online, addresses these questions. Most trials target brain pathologies In the review, specialists from the Alzheimer’s Drug Discovery Foundation in New York, NY analyze current clinical trials for dementia drugs and advise about the best approach going forward. “Alzheimer’s is […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News MONDAY, Nov. 4, 2019 (HealthDay News) — Could one woman’s rare genetic mutation one day have a global impact on dementia risk? It’s possible, say investigators who report on a potentially groundbreaking case of a woman whose genetic mutation staved off dementia for decades, even though her brain had already been damaged by Alzheimer’s disease. While most Alzheimer’s cases are not driven by genetic predisposition, one woman in Colombia is among about 1,200 in her country who do face a genetically higher risk for early-onset Alzheimer’s. Why? They all carry the E280A mutation of a gene called Presenilin 1 (PSEN1), which is known to increase the chances for Alzheimer’s at a far younger age than usual. “We identified an individual that was predisposed to develop Alzheimer’s in her 40s,” noted study author Dr. Joseph Arboleda-Velasquez. He’s an assistant professor of ophthalmology with the Schepens Eye Research Institute of Mass Eye and Ear at Harvard Medical School, in Boston. But, strangely, the woman “remained unimpaired until her 70s,” Arboleda-Velasquez added. The twist: the woman had, in fact, developed clear telltale signs of Alzheimer’s in her brain. She just hadn’t developed dementia. For example, while […]
Research has linked a particular sleep disorder called rapid eye movement (REM) sleep behavior disorder with a diagnosis of Parkinson’s disease. What characterizes this sleep problem, and can its presence be a good way to predict Parkinson’s risk? People who experience a sleep disorder that causes them to act out their dreams have a high risk of developing Parkinson’s disease. Data from the National Institutes of Health (NIH) indicate that every year, approximately 50,000 people in the United States learn that they have Parkinson’s disease, a neurological condition that affects a person’s motor function and exposes them to other neurodegenerative problems, such as Alzheimer’s disease. Researchers still do not fully understand exactly what causes Parkinson’s disease, but they have identified a few risk factors that can predispose a person to develop this condition. These include a person’s age and sex as well as some genetic factors. Still, it remains a challenge to establish early on who is likely to develop Parkinson’s disease at some point in their life. However, a team of researchers from McGill University in Montreal, Canada decided to see if one particular factor — a sleep disorder called REM sleep behavior disorder (RBD) — could be a […]
(HealthDay News) — If a loved one has symptoms of Alzheimer’s disease, he or she should visit a doctor for a formal evaluation. Latest Alzheimer’s News It may be easier to control the disease if it’s diagnosed early, the Alzheimer’s Association says. Here is the association’s list of other potential benefits of early diagnosis: Better access to treatment options. Possible participation in a clinical trial. More time to improve health concerns, such as obesity and high blood pressure. More time to spend with family and planning for the future. Copyright © 2019 HealthDay. All rights reserved.
By Serena GordonHealthDay Reporter Latest Alzheimer’s News TUESDAY, March 5, 2019 (HealthDay News) — Most seniors expect their doctor to recommend testing of thinking and memory when it’s needed. But a new survey discovered that is rarely the case: Only one in seven seniors received a regular assessment for memory and thinking (or “cognitive”) troubles. That finding is in sharp contrast to those who receive assessments for other common health issues. Ninety-one percent of seniors said they were regularly checked for blood pressure, and 83 percent said their cholesterol levels were routinely tested. “Both doctors and patients have a strong belief that cognitive assessment is important, but there’s a disconnect about who should bring it up,” explained Joanne Pike, chief program officer at the Alzheimer’s Association, which conducted the survey. The survey found that most seniors thought that the doctor would recommend such screening when it was necessary. Meanwhile, doctors were waiting for patients or family members to report that someone might be having memory issues. Pike said that while seniors reported believing that early detection of memory and thinking issues would be beneficial, many didn’t tell their doctors about their own memory concerns. “Half of all seniors were aware […]
Researchers found that using a computer, playing games, and participating in social activities may reduce the risk of mild cognitive impairment. New research suggests that playing games, using a computer, and having a rich social life can keep mild cognitive impairment at bay. Our brains go through changes as we get older, and some people may experience issues with memory, thinking, or judgment. Mild cognitive impairment (MCI) is the stage between age-related cognitive decline and dementia — however, MCI does not significantly affect daily life and activities. People with MCI tend to forget things, lose their train of thought or the thread of conversations, and feel overwhelmed by making decisions. According to the Centers for Disease Control and Prevention (CDC), more than 16 million people in the United States are living with cognitive impairment. MCI may increase the risk of dementia, but not everyone with MCI goes on to develop the condition. To date, the Food and Drug Administration (FDA) have not approved any treatments specifically for MCI. Lifestyle choices such as physical exercise and intellectual stimulation have positive effects on the brain. In recent years, researchers have been conducting more studies to find treatments that may prevent cognitive decline. […]
By Karina Lichtenstein on 10/28/2019 3:26 PM Latest Alzheimer’s News Source: MedicineNet Health News Donuts, flaky pastries, and cakes can be tasty, but eating some of them may come at a price. Eating foods high in trans fats may greatly increase your risk of Alzheimer’s and other types of dementia, per the results of a new study in the journal Neurology. For 10 years researchers followed 1,600 Japanese men and women aged 60 and older who did not have dementia. Those who had the highest blood levels of trans fats had a 75% higher risk of developing Alzheimer’s and other types of dementia over that time period compared to those who had the lowest levels, according to the study. What Increases Alzheimer’s Risk? Alzheimer’s disease is a progressive brain disease that causes memory impairment and eventually disturbances in planning, reasoning, language, and perception, according to MedicineNet author Howard Crystal, MD. Increasing age is the main risk factor for Alzheimer’s disease, Dr. Crystal said. Approximately 15% of people over the age of 65 have the condition, but that number increases to 50% of people over the age of 85. Alzheimer’s rates in the U.S. are skyrocketing, with an estimated 13.8 million […]
Older people who want to preserve their faculties may wish to consider rationing their TV time. A large new study of older adults found that those who spent at least 3.5 hours per day watching TV experienced a greater decline in verbal memory. The ‘passive activity’ of watching TV may impair memory in older people. Researchers at University College London in the United Kingdom analyzed data from the English Longitudinal Study of Ageing (ELSA) on 3,662 adults aged 50 and older. In 2008–2009, and again in 2014–2015, the ELSA participants had answered questions about the time they spent watching TV. At these times, they also completed tests of verbal memory and fluency. The analysis revealed that those who watched TV for 3.5 hours or more per day had an average decline of 8–10 percent in word- and language-related memory over the 6 years the study covered. This is compared with a lower 4–5 percent average decline in those who watched fewer hours of TV per day over the same period. The study, which now features in the journal Scientific Reports, found no such links between TV viewing time and differences in “semantic fluency.” The verbal memory tests asked the participants […]
Gum disease is common and unpleasant, but, according to a growing body of evidence, it could also play a role in a surprising range of seemingly unrelated health problems. Cleaning your teeth may be even more important than you thought. Plaque — a sticky substance that contains bacteria — builds up on teeth. If it is not brushed away, the bacteria can irritate the gums. The gums may then become swollen, sore, or infected; this is referred to as gingivitis. In general, gum disease can be treated or prevented by maintaining a good oral health regime. However, if it is left to develop, it can result in periodontitis, which weakens the supporting structures of the teeth. Gum disease, which is also called periodontal disease, is widespread. According to the Centers for Disease Control and Prevention (CDC), almost half of adults in the United States have some degree of gum disease. The mechanisms behind periodontal disease are relatively well-understood, and newer research shows that this health problem may play a role in the development of a number of other conditions, including Alzheimer’s disease, cancer, and respiratory disease. In this Spotlight, we will cover some of the surprising links between gum disease […]
An existing blood thinner — used to prevent the formation of blood clots in people at risk of stroke — could help delay the development of Alzheimer’s disease, according to a new study in a mouse model. Could a common blood thinner help people with Alzheimer’s disease? Alzheimer’s disease is the most common form of dementia, a neurodegenerative condition in which people experience progressive memory loss. Some treatments can help people with Alzheimer’s disease manage this symptom and others to a certain extent. However, there is currently neither a cure nor a tried and true method of preventing the condition. This is why researchers worldwide continue to search for strategies and therapies that could at least delay the onset of Alzheimer’s symptoms. This is also what a team of investigators — many from the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in Madrid, Spain, and The Rockefeller University, in New York — has recently investigated. In a new study, coordinated by Marta Cortés Canteli, Ph.D., the team has used a known anticoagulant, a drug that prevents blood clots, to slow the onset of Alzheimer’s disease symptoms in a mouse model. The researchers took this approach because previous studies have shown that […]
A novel genetic approach that repairs broken connections between brain cells could lead to treatments that restore memory capacity in Alzheimer’s disease. By using epigenetics, it may soon be possible to reverse memory loss in Alzheimer’s disease. The new approach reverses changes to gene expression that tend to occur in the later stages of the disease. Scientists at State University of New York at Buffalo demonstrated how the method was able to reverse Alzheimer’s memory decline in mice. Much genetic research on the causes of Alzheimer’s disease focuses on changes in the DNA of genes. The new study, however, focuses on epigenetics, which concerns mechanisms that can switch genes on and off without disturbing their DNA code. A paper about the work now features in the journal Brain. “In this paper,” says senior study author Zhen Yan, Ph.D., who is a professor in the Department of Physiology and Biophysics, “we have not only identified the epigenetic factors that contribute to the memory loss, we also found ways to temporarily reverse them in an animal model of [Alzheimer’s disease].” Alzheimer’s disease and loss of synapses Alzheimer’s disease is the leading cause of dementia. According to the World Health Organization (WHO), between […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Dec. 13, 2018 (HealthDay News) — A brain protein linked to Alzheimer’s disease might potentially be transmitted to people during neurological procedures, a new preliminary study suggests. Genetically engineered lab mice developed amyloid-beta deposits in their brains after they were injected with amyloid-laced samples of human growth hormone taken from decades-old human cadavers, researchers found. “We have now provided experimental evidence to support our hypothesis that amyloid-beta pathology can be transmitted to people from contaminated materials,” said senior researcher Dr. John Collinge. He is head of University College London’s department of neurodegenerative disease. Clumps of amyloid-beta in the brain are a hallmark of Alzheimer’s disease, although researchers still don’t understand the relationship between these clumps and the degenerative brain disease. Collinge pointedly noted that this study does not mean that you can catch Alzheimer’s from another person. And animal findings often don’t replicate in humans. “Although we’re generating evidence that Alzheimer’s pathology may be transmissible, there’s absolutely no suggestion that Alzheimer’s disease itself is a contagious disease,” he said. Rebecca Edelmayer, director of scientific engagement at the Alzheimer’s Association, went even further, noting that the new study did not look at Alzheimer’s […]
Latest Alzheimer’s News THURSDAY, Aug. 8, 2019 (HealthDay News) — Want to reduce your risk of dementia? Take care of your heart. That’s the takeaway from a new study that suggests good heart health in middle age could lower your odds for problems with thinking and memory later in life. The study included nearly 7,900 British adults who did not have heart disease or dementia at age 50. Over an average 25-year followup, 347 cases of dementia were diagnosed among participants. Average age at diagnosis: 75. After taking other factors into account, researchers linked a higher score at age 50 on seven healthy habits outlined in the American Heart Association’s “Life Simple 7” with a lower risk of dementia later in life. The Life Simple 7 assesses smoking, diet, physical activity, fasting blood sugar, blood cholesterol, blood pressure and body mass index (a measure of body fat based on height and weight). Dementia rates were 1.3 per 1,000 person years among participants who had high scores on heart healthy habits, compared to 3.2 per 1,000 for low-scorers, according to the study published Aug. 7 in the BMJ. A better score at age 50 was also associated with higher overall brain […]
Memory can deteriorate naturally, due to age, and even when this process is not related to neurodegenerative conditions, such as Alzheimer’s, it can still affect a person’s quality of life. Now, researchers from Boston University in Massachusetts are exploring ways of fighting age-related memory decline. By resynchronizing brain waves, we could reverse some age-related memory problems. “Working memory […] is a fundamental building block of human cognition,” explains Robert Reinhart, Ph.D., the director of the university’s Visual Cognitive Neuroscience Laboratory. “It’s been called, classically, the ‘workbench of the mind’ or the ‘sketchpad of the mind.’ It allows us to hold information in our minds over a period of seconds,” he continues. Essentially, this is the type of memory that allows a person to make spontaneous calculations and assessments, and navigate daily life situations. But working memory also starts to naturally decline with age, which means that, as a person grows older, they may find it more difficult to perform some tasks, such as keeping track of their finances. “Working memory […] is where we think, where we problem-solve, where we reason, plan, perform mathematical calculations, make decisions. It’s essentially where consciousness lives.” Robert Reinhart, Ph.D. For this reason, Reinhart and […]
A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. A potential treatment for Alzheimer’s moves a step closer. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf, both in Germany, developed the candidate drug, which, for now, bears the name PRI-002. PRI-002 eliminates toxic beta-amyloid oligomers, the self-replicating proteins that scientists suspect of causing and advancing Alzheimer’s disease. The team had previously shown that the drug could significantly reduce signs and symptoms in older mice that were genetically engineered to develop an Alzheimer’s-like disease through the insertion of a mutant human gene. That preclinical study featured online in 2018 in the journal Molecular Neurobiology. In the ensuing, recently completed phase 1 clinical trial, healthy volunteers took daily dosages of PRI-002 for 4 weeks. The results show that the drug is safe for human use. Passing this stage of testing in humans means that the candidate drug can now proceed to a phase 2 trial to evaluate its effectiveness in people with Alzheimer’s disease. “Our next goal is the proof of efficacy in […]
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
WEDNESDAY, May 15, 2019 (HealthDay News) — Regular exercise, eating a healthy diet, watching your blood pressure, avoiding tobacco and limiting alcohol intake can reduce your risk of dementia, according to World Health Organization guidelines released Tuesday. Latest Alzheimer’s News The WHO also cautioned against taking dietary supplements such as Vitamins B and E in an attempt to prevent mental decline and dementia, CNN reported. Dementia affects 50 million people worldwide and there is no effective treatment. “While some people are unlucky and inherit a combination of genes that makes it highly likely they will develop dementia, many people have the opportunity to substantially reduce their risk by living a healthy lifestyle,” Tara Spires-Jones, U.K. Dementia Research Institute program lead and deputy director of the Center for Discovery Brain Sciences at the University of Edinburgh, U.K. told the Science Media Center, CNN reported. “The WHO has looked at the available evidence and made recommendations that some lifestyle changes, in particular increasing exercise before any cognitive symptoms are present, can reduce dementia risk,” she explained. In terms of healthy eating, the WHO said your best bet is the Mediterranean diet, which emphasizes lots of fruits and vegetables and olive oil, CNN […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News TUESDAY, Jan. 29, 2019 (HealthDay News) — Tight control of your blood pressure won’t necessarily spare you from full-blown dementia, a new trial concludes. But it might lower the risk of slight declines in thinking and memory, a condition known as mild cognitive impairment (MCI), the researchers added. The clinical trial is the “first study in history to show that any intervention can reduce your risk of developing mild cognitive impairment, an early form of dementia,” said lead researcher Dr. Jeff Williamson. He is a professor of gerontology and geriatric medicine at Wake Forest School of Medicine, in Winston-Salem, N.C. “What is good for your heart in terms of blood pressure-lowering is also good for your brain,” Williamson added. He noted that the trial ended early, which likely affected the dementia result. “We just didn’t have enough dementia cases develop over time” in the group with less-restricted blood pressure, he explained. High blood pressure affects more than three-fourths of people over the age of 65, and it has been identified as a potential risk factor for MCI and dementia in observational studies, the study authors said in background notes. The new clinical trial […]
Type 2 diabetes is a chronic condition that affects the body’s insulin production and blood sugar levels. New research, however, suggests that the scope of this condition may be broader than previously thought, as scientists find a link between type 2 diabetes and cognitive decline over 5 years. New research suggests that type 2 diabetes may affect brain size in midlife. Michele Callisaya, from the University of Tasmania in Hobart, Australia, led the new research. Callisaya and her colleagues set out to investigate if there was an association between type 2 diabetes, on the one hand, and brain atrophy and cognitive decline, on the other. Moreover, in case the researchers found such a connection, they wanted to discover whether there was a causal relationship underlying it. The researchers recruited 705 people aged between 55 and 90 years from the so-called Cognition and Diabetes in Older Tasmanians study and took measures of the participants’ brains and cognition. To the authors’ knowledge, this is the first study to compare both cognition and brain size among people with and without type 2 diabetes. The results appear in Diabetologia, the journal of the European Association for the Study of Diabetes. Type 2 diabetes tied […]
Latest Alzheimer’s News MONDAY, Sept. 23, 2019 (HealthDay News) — Many older people show evidence of mental decline, called mild cognitive impairment, but doctors often miss this sometimes early sign of dementia and Alzheimer’s disease. To help doctors get a better handle on their patients’ mental state, the American Academy of Neurology (AAN) is urging physicians to assess patients aged 65 and older at least once a year. The academy recommends that doctors use a mathematical tool that helps quantify their patients’ memory and thinking skills. “Since thinking skills are the most sensitive indicator of brain function and they can be tested cost-effectively, this creates an enormous opportunity to improve neurologic care,” study author Dr. Norman Foster, of the University of Utah in Salt Lake City, said in an AAN news release. Around the world, nearly 7% of people in their early 60s suffer from mild cognitive impairment, as do 38% of those aged 85 and older, according to the AAN. Using the new metric can alert doctors so that optimal care can be provided. Although there is no cure for mild cognitive impairment, its presence can help doctors keep watch should the patient progress to dementia. “We cannot expect […]
A blood test can identify the protein that builds up in the brains of people with Alzheimer’s nearly 20 years before symptoms appear, a new study shows. A simple blood test could soon predict symptoms of Alzheimer’s disease decades before they appear. The study found that the blood test was even more sensitive at detecting the buildup of beta-amyloid proteins in the brain than the current gold standard, which is a PET brain scan. Researchers from Washington University School of Medicine (WUSTL) in St. Louis, MO, conducted the study, which appears in the journal Neurology. First author Dr. Suzanne Schindler, an assistant professor of neurology, led the researchers, who first developed a version of this test a couple of years ago. The test uses mass spectrometry on blood samples to detect the presence of two forms of the beta-amyloid protein: beta-amyloid 42 and beta-amyloid 40. When beta-amyloid deposits in the brain start to build up, the ratio between the two forms of the protein goes down. The blood test can detect this change. The study involved 158 adults who were at least 50 years old, and all but 10 had normal cognitive function. For the study, each person had a […]
Scientists have now proved that drinking certain types of coffee can be beneficial to brain health, but how does this popular brew support cognitive function? A new study identifies some of the mechanisms that allow coffee to keep mental decline at bay. What makes coffee an ally of brain health? According to data from the Harvard T.H. Chan School of Public Health in Boston, MA, about 54 percent of all adults in the United States drink coffee on a daily basis. While drinking coffee can bring both benefits and risks for a person’s health, a 2016 study from the University of Ulster in Coleraine, United Kingdom, concluded that the health benefits of moderate coffee consumption “clearly outweigh” the potential risks. One of these benefits is that coffee seems to protect the brain against cognitive impairments and boost thinking skills. How does this happen, and what is it about coffee that is so beneficial to cognitive health? These are some questions that a new study from the Krembil Brain Institute — part of the Krembil Research Institute in Toronto, Canada — aims to answer. “Coffee consumption does seem to have some correlation to a decreased risk of developing Alzheimer’s disease and […]
New research finds that eye tracking tests can accurately detect people who have a form of mild cognitive impairment that predisposes them to Alzheimer’s disease. The direction of a person’s gaze can be a telltale sign of cognitive impairment. Alzheimer’s disease often evolves from mild cognitive impairment (MCI) — a small decline in memory and reasoning that is not serious enough to interfere with daily activities, but that is noticeable to the person who develops the condition. In fact, according to some studies, 46% of people with an MCI diagnosis go on to develop dementia within 3 years. By comparison, only 3% of adults of the same age experience Alzheimer’s in the same time span. However, MCI does not always develop into full blown dementia. It often remains stable and sometimes the symptoms disappear completely with the person reverting to a normal, healthy cognition. Experts have divided MCI into two forms: amnesic (aMCI) and nonamnesic (naMCI). The former describes impairment that predominantly affects memory, whereas the latter affects other cognitive skills. Having aMCI raises the risk of Alzheimer’s significantly more than naMCI. Detecting Alzheimer’s as early as possible improves a person’s brain health and may reduce their symptoms, especially if […]
A large new study has found a link between taking various kinds of blood pressure-lowering drugs and a lower risk of dementia among older adults, adding to the discussion around the link between cognitive decline and high blood pressure. People who take blood pressure-lowering medication may have a lower risk of dementia. Dementia is an umbrella-term for various neurodegenerative conditions, the most widespread of which is Alzheimer’s disease. The main characteristic of dementia is progressive cognitive decline, wherein a person experiences memory loss and a decline in their thinking and decision-making abilities. Researchers are still uncertain as to what causes dementia, but in an effort to improve prevention strategies, they have been studying the potential risk factors that may contribute to the development of this condition. Many recent studies have linked hypertension with a higher risk of dementia. For instance, a paper that appeared in the journal Neurology last year found that hypertension is tied to a higher risk of experiencing brain lesions, which are, in turn, tied to dementia. Now, a large study that used data from the Disease Analyzer database — which is a large German database that collects and stores the health information of millions of people […]
New research, published in the journal Nature Genetics, identifies new genetic risk factors for Alzheimer’s disease. It also uncovers novel biological mechanisms that may lead to this neurodegenerative condition. Scientists have found new genetic locations associated with Alzheimer’s. About 5.7 million people in the United States are currently living with Alzheimer’s disease. A recent report issued by the Centers for Disease Control and Prevention (CDC) predicts that by the year 2060, this number will grow to 13.9 million. Genes play an important role in whether a person will develop Alzheimer’s or not. Researchers estimate that 60–80 percent of the disease is heritable. Therefore, identifying the genes that put some people at risk of Alzheimer’s is an important scientific endeavor. So far, studies have found more than 20 genetic locations that have links with the condition, but these only explain a small percentage of the genetic variance that accounts for Alzheimer’s. So, a team of scientists has set out to uncover more genetic risk factors. Professor Danielle Posthuma, from the Vrije Universiteit University in Amsterdam, Netherlands, together with Dr. Ole Andreassen from the University of Oslo, Norway, and Dr. Stephan Ripke from the Broad Institute in Boston, MA, led the new […]
Parkinson’s disease is a neurological condition with a wide range of effects, including problems with movement, blood pressure and thinking, and mood, sensory, and sleep difficulties. The symptoms of Parkinson’s disease (PD) usually begin gradually, and they affect each person differently. The symptoms a person has will vary widely, regardless of how severe they are or how quickly they develop. Read on to find out more about the different types of symptoms and how to recognize the early symptoms of PD. Early symptoms Around 7 out of 10 people with PD experience tremor at some stage. The symptoms of PD affect individuals differently, but some can be an early sign of the disease. These are: REM sleep disorder and other sleep problems the loss of the sense of smell tremor, especially in one hand a smaller size of handwriting difficulty moving or walking or a stooping gait constipation loss of facial expression, that may make the person look emotionless a low or soft voice Primary motor symptoms The four main signs and symptoms include: slow physical movements, known as bradykinesia shaking, or tremor muscle stiffness, or rigidity problems with balance and coordination, known as postural instability Symptoms often start on […]
Latest Alzheimer’s News TUESDAY, Jan. 22, 2019 (HealthDay News) — Leaky blood vessels in the brain may be an early sign of Alzheimer’s disease, researchers say. They followed 161 older adults for five years and found that those with the most severe memory declines had the greatest leakage in their brain’s blood vessels, regardless of whether the Alzheimer’s-related proteins amyloid and tau were present. The findings could help with earlier diagnosis of Alzheimer’s and suggest a new drug target for slowing down or preventing the disease, according to the researchers from the University of Southern California. “The fact that we’re seeing the blood vessels leaking, independent of tau and independent of amyloid, when people have cognitive [mental] impairment on a mild level, suggests it could be a totally separate process or a very early process,” said study senior author Dr. Berislav Zlokovic. He is director of the Zilkha Neurogenetic Institute at the university’s Keck School of Medicine in Los Angeles. “That was surprising, that this blood-brain barrier breakdown is occurring independently,” Zlokovic added in a university news release. The blood-brain barrier prevents harmful substances from reaching brain tissue. In some people, this barrier weakens with age. “If the blood-brain barrier […]
New research finds that an HIV enzyme plays a crucial role in driving Alzheimer’s-related brain pathology by altering the APP gene. The findings warrant “immediate clinical evaluation of HIV antiretroviral therapies in people with Alzheimer’s disease,” say the authors of the study. The revelations of a recent study suggest that HIV drugs might successfully treat Alzheimer’s disease. Deemed “the most under-recognized public health crisis of the 21st century,” Alzheimer’s disease is the 6th leading cause of death in the United States and has no known cure. Currently, 5.7 million people ln the U.S. are living with the condition, and the Centers for Disease Control and Prevention (CDC) predict that the burden of the disease will double by 2060. Alzheimer’s also puts a significant strain on the American healthcare system. According to recent estimates, Alzheimer’s and other forms of dementia cost the U.S. $226 billion in 2015, and loved ones spend billions of unpaid hours caring for people with the condition. About 40 percent of these caregivers develop depression. The medical community is hard at work trying to understand how this debilitating disorder occurs and what can be done to stop it. For instance, one of the clues that researchers have […]
(HealthDay News) — If you are caring for a loved one who has Alzheimer’s disease, you may develop feelings of grief as the person starts to change, the Alzheimer’s Foundation says. Latest Alzheimer’s News There are five phases of grieving: denial, anger, guilt, sadness and acceptance. The association suggests how to cope with grief and loss: Face your feelings and accept them. Prepare to have feelings of loss as dementia progresses. Understand that no two people grieve in exactly the same way. Talk with someone you trust about your feelings. Stay involved in activities that you enjoy. Join a support group. Accept things that you cannot change. Take care of yourself. Copyright © 2018 HealthDay. All rights reserved. CONTINUE SCROLLING FOR NEXT NEWS ARTICLE
Building on decades of research, a new paper brings us one step closer to a vaccine that targets the neurological hallmarks of Alzheimer’s disease. Prevention may soon be possible. Scientists inch closer to finding a way to prevent Alzheimer’s disease. Alzheimer’s disease, the most common form of dementia, is a degenerative neurological disease. Memory issues are often the first sign of the condition, which steadily progresses over time. Alzheimer’s disease is a growing concern as it appears almost exclusively in older adults. As the number of older people rises in the United States, the number of cases will also increase. Although scientists are still investigating the exact causes of Alzheimer’s disease, they believe that certain neurological markers play a significant role. The disease seems to involve a buildup of specific proteins in the brain called beta-amyloid and tau. Doctors refer to these abnormal congregations as plaques and neurofibrillary tangles respectively. The hunt for a vaccine Current treatments for Alzheimer’s do not stop disease progression, so the search for effective alternatives is ongoing. Some researchers hope that targeting amyloid buildup might make it possible to stop Alzheimer’s in its tracks. Many scientists are on the hunt for a vaccine, including Dr. […]
As we age, we may experience a decline in our mental ability. A recent study has concluded that chronic inflammation in midlife might speed up this decline as we get older. Could influencing inflammation slow cognitive decline? The average age of the population of the United States is gradually increasing, so conditions of old age are moving into the spotlight. Growing older is associated with a progressive decline in average thinking abilities. However, it may only affect some people very mildly, while other individuals can develop significant cognitive deficits. Understanding the risk factors involved is of growing importance. We already know some risk factors; for instance, lower levels of physical activity, smoking, and obesity appear to increase the rate of decline. Recently, some scientists have turned their attention toward the potential role of inflammation. Inflammation and its consequences As a protective mechanism that prevents any damage to tissue, inflammation occurs in response to an infection or injury. However, if this acute inflammation continues for longer periods — which doctors call chronic inflammation — it can cause damage. Scientists have already linked inflammation to a range of health concerns, including cardiovascular disease, cancer, diabetes, and asthma. Could inflammation also have a […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News FRIDAY, June 21, 2019 (HealthDay News) — Researchers have found more evidence of a puzzling phenomenon: Older adults who survive cancer seem to be somewhat protected against dementia. A number of studies in recent years have found that cancer survivors have a relatively lower risk of developing Alzheimer’s. The new research adds another layer. It shows that even before their diagnosis, older adults who go on to develop cancer have an edge when it comes to memory performance. Among the older Americans who were tracked for 16 years, those who developed cancer typically had sharper memory skills — both before and after the diagnosis — than those who remained cancer-free. Researchers said it all supports the theory that some of the biological processes that contribute to cancer may actually protect against dementia. But the big remaining question is, what are those mechanisms? “We’re really interested in understanding what [they] could be, because it might point the way to strategies to prevent dementia,” said senior researcher Maria Glymour, a professor at the University of California, San Francisco School of Medicine. The study findings are based on more than 14,500 U.S. adults born before 1949. […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News TUESDAY, March 12, 2019 (HealthDay News) — A long-running study questions the conventional wisdom that a healthy diet may help ward off dementia. European researchers followed more than 8,200 middle-aged adults for 25 years — looking at whether diet habits swayed the odds of being diagnosed with dementia. In the end, people who ate their fruits and vegetables were at no lower risk than those who favored sweets and steaks. The findings, published March 12 in the Journal of the American Medical Association, stand in stark contrast to many past studies. Those studies have linked heart-healthy diets to lower odds of mental decline and abnormalities in the brain that can foretell dementia. Currently, groups like the Alzheimer’s Association suggest that people adopt those diets as one potential way to stave off dementia. Most studies, though, have followed people for only a fairly short time — less than 10 years, said lead researcher Tasnime Akbaraly, from the French national research institute INSERM. This study is the first to look at diet quality starting in middle age and the long-term risk of dementia, explained Akbaraly. Her team found that 344 people were diagnosed with Alzheimer’s […]
Latest Alzheimer’s News WEDNESDAY, June 5, 2019 (HealthDay News) — If someone you know is struggling to keep track of their finances as they age, early dementia might be the culprit. That’s the conclusion of researchers who tested 243 adults, aged 55 to 90, on their financial skills and performed brain scans to assess the buildup of beta-amyloid plaques, which are associated with Alzheimer’s disease. Some of the participants had no mental decline, some had mild memory impairment and some had been diagnosed with Alzheimer’s disease. Specific financial skills declined with age and at the earliest stages of mild memory impairment, with similar declines in men and women, the study authors said. “There has been a misperception that financial difficulty may occur only in the late stages of dementia, but this can happen early and the changes can be subtle,” said senior study author P. Murali Doraiswamy. He is a professor of psychiatry and geriatrics at Duke University, in Durham, N.C. After accounting for education levels and other factors, the researchers found that the more extensive the amyloid plaques were, the worse a person’s ability to understand and use basic financial concepts or to complete financial tasks, such as calculating […]
By Serena GordonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Feb. 6, 2019 (HealthDay News) — There are plenty of good reasons to seek a higher education, but avoiding Alzheimer’s disease probably isn’t one of them, new research suggests. The study found that a person’s level of education wasn’t related to the onset of memory and thinking (“cognitive”) troubles, or the rate at which dementia progressed. “Education is related to cognitive growth in early life, but it wasn’t associated with cognitive change as you age. What’s more important is what you’re doing now, than what you did 40 or 50 years ago,” explained study author Robert Wilson. He’s a neuropsychologist at Rush University Medical Center in Chicago. Wilson said that continuing to do things such as learning a new language, social activities, having a purpose in life, or engaging in mentally demanding work may help keep your brain sharper as you get older. Previous research has hinted that there might be a link between education and a person’s risk of developing dementia or Alzheimer’s disease, or how fast the disease advances. But the results of a number of studies looking at this possible link have had mixed results. To try to get […]
A recent article raises important questions about the prevalence of firearms in the aging population of the United States. The authors argue that there is a vital need to discuss the relationship between dementia and guns. A recent article investigates the issue of gun ownership in an aging population. Gun ownership is a controversial topic, and people are sure to continue debating it for many years to come. This debate often focuses on young men and violent crime, but a recent article investigates the other end of the age spectrum. Older adults are more likely to own a gun than younger people. An estimated 27 percent of people over the age of 65 years own at least one gun, while 37 percent live in a home where a firearm is present. A seemingly unrelated but equally hot topic is the rise of dementia. Dementia and firearms As dementia occurs almost exclusively later in life, the longer that people live, the more prevalent it becomes. Currently, around 5.7 million people in the U.S. are living with Alzheimer’s disease. Although Alzheimer’s is the most common form of dementia, it only accounts for 60–80 percent of all dementia cases. A recent article in […]
New research suggests that vital exhaustion, a marker of psychological distress, may raise the risk of developing Alzheimer’s disease. Psychological distress in midlife may bring about dementia later on, suggests new research. Many factors may increase Alzheimer’s risk, including age, family history, and genetic makeup. Certain health issues, such as cardiovascular disease or diabetes, may also influence the odds of experiencing dementia because they impact the blood vessels. New research indicates that psychological factors could also affect risk. Psychological distress, in particular, may increase the likelihood of developing dementia, suggests the new study. Specifically, researchers led by Sabrina Islamoska, a doctoral candidate in the Department of Public Health at the University of Copenhagen, Denmark, set out to investigate the possibility of a link between vital exhaustion and Alzheimer’s disease. Vital exhaustion describes “a mental state of psychological distress” that manifests as irritability, fatigue, and a feeling of demoralization. As the researchers explain, vital exhaustion may be a reaction to “unsolvable problems” in one’s life, especially when the person has been exposed to stressors for a prolonged period. So, vital exhaustion can be seen as a sign of psychological distress. Previous studies have noted that vital exhaustion may raise the risk […]
(HealthDay News) — Memory loss is common, but should not be taken lightly, says Mayo Clinic. If you have difficulty remembering things, Mayo Clinic offers a few simple ways to sharpen your memory: Stay physically and mentally active. Socialize often. Stay organized. Sleep well. Eat healthy. Manage chronic conditions. Latest Alzheimer’s News If memory loss affects your ability to complete your daily activities, or if you notice it getting worse, talk with your doctor. Copyright © 2019 HealthDay. All rights reserved.
An artificial intelligence tool taught to analyze brain scans can accurately predict Alzheimer’s disease several years before a final diagnosis. Researchers used PET scans to train a deep learning algorithm to predict signs of Alzheimer’s. The team responsible suggests that, after further validation, the tool could greatly assist the early detection of Alzheimer’s, giving treatments time to slow the disease more effectively. The researchers, from the University of California in San Francisco, used positron-emission tomography (PET) images of 1,002 people’s brains to train the deep learning algorithm. They used 90 percent of the images to teach the algorithm how to spot features of Alzheimer’s disease and the remaining 10 percent to verify its performance. They then tested the algorithm on PET images of the brains of another 40 people. From these, the algorithm accurately predicted which individuals would receive a final diagnosis of Alzheimer’s. On average, the diagnosis came more than 6 years after the scans. In a paper on the findings, which the Radiology journal has recently published, the team describes how the algorithm “achieved 82 percent specificity at 100 percent sensitivity, an average of 75.8 months prior to the final diagnosis.” “We were very pleased,” says co-author Dr. […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, May 29, 2019 (HealthDay News) — Here’s another reason to keep your cholesterol under control: New research suggests that LDL, or “bad,” cholesterol may play a role in the development of early-onset Alzheimer’s. A rare form of the disease that occurs before the age of 65, early-onset Alzheimer’s has previously been linked to a gene mutation involved in how the body processes fats and cholesterol. But that mutation only accounts for a small percentage of cases, the scientists noted. Their new research suggests that “LDL cholesterol levels [also] play a causal role in the pathogenesis of Alzheimer’s disease,” said lead researcher Dr. Thomas Wingo. He’s an assistant professor of neurology at Emory University School of Medicine in Atlanta. “The big question is whether there is a causal link between cholesterol levels in the blood and Alzheimer’s disease risk,” Wingo said. “The existing data is murky on this point. Our current work is focused on testing whether there is a causal link.” Most early-onset Alzheimer’s disease is not explained by known gene mutations, Wingo added. The APOE genetic mutation, called APOE E4, raises levels of LDL cholesterol. High levels of this type of […]
In the future, a doctor might be able to tell whether someone is heading toward Alzheimer’s disease — not by carrying out expensive brain scans, but during an eye exam. One day, a simple eye test might help predict the onset of Alzheimer’s. A new study paper in the journal Ophthalmology Retina outlines research that took place at Duke Eye Center in Durham, NC. The researchers propose that a loss in density of blood vessels in the retina could suggest development of Alzheimer’s disease. Researchers studied more than 200 people with normal brain function as well as individuals with Alzheimer’s. They used a technique called optical coherence tomography angiography (OCTA), which is noninvasive and can reveal blood flow in every layer of the retina. In the control group, they found that the web of tiny blood vessels located at the back of the eye was quite dense. The vessels of those with Alzheimer’s disease, however, were less dense. In some cases, they were also much more sparse. Senior study author Dr. Sharon Fekrat, an ophthalmologist and retinal surgeon at Duke Eye Center, notes that they measured blood vessels that are not normally seen during a routine eye exam. She explains […]
Men who follow a healthful diet could be protecting their brains, according to a new study that tracked a large group of men for more than 2 decades. Leafy greens and red and orange vegetables correlated with reduced memory loss in a new study. Researchers from the Harvard T.H. Chan School of Public Health in Boston, MA, analyzed data from a study that had followed 27,842 men for 26 years. The men had all filled in detailed surveys about their food and drink intake at the start of the study in 1986 — when they were aged 51 years, on average — and then every 4 years until 2002. The follow-up lasted until 2012, by which time their average age was in the mid- to late-70s. During the last few years of the follow-up, they had also completed short tests to find out whether they had noticed any decline in their own ability to think and remember things. The analysis showed that consuming higher amounts of certain foods and drinks was tied to lower risk of decline in memory and thinking skills. The foods that most strongly showed this effect were leafy greens, red and dark orange vegetables, berry fruits, […]
Latest Alzheimer’s News MONDAY, Aug. 12, 2019 (HealthDay News) — New research is untangling the complex relationship between symptoms of depression and losses in memory and thinking that often emerge together with Alzheimer’s disease. In fact, the new data suggests that “depression symptoms themselves may be among the early changes in the preclinical stages of dementia syndromes,” explained study lead author Dr. Jennifer Gatchel. She works in the division of geriatric psychiatry at Massachusetts General Hospital in Boston. In the study, researchers examined brain scans and other data gathered over seven years from 276 older adults enrolled in the Harvard Aging Brain Study. All of the participants were still living independently in the community at the beginning of the study and were considered healthy. However, the analysis revealed a significant link between worsening depression symptoms and mental decline over two to seven years, and both of these trends seemed to be linked to a buildup of amyloid protein in brain tissue. The slow accumulation of amyloid has long been known as a hallmark of Alzheimer’s disease. “Our research found that even modest levels of brain amyloid deposition can impact the relationship between depression symptoms and cognitive [thinking] abilities,” Gatchel said […]
The causes of dementia can damage the brain in different ways. Is it possible that these differences may reveal themselves in the way that people walk? A new study that compared walking patterns in people with two types of dementia explored the question. New research suggests a person’s gait may offer clues into the type of dementia they are living with. “Alzheimer’s and Lewy body disease have unique signatures of gait impairment,” state the authors in a recent Alzheimer’s & Dementia paper about their findings. The researchers suggest that the unique impairments to gait — or alterations to walking pattern — may reflect the specific damage that each disease inflicts on mental function and the brain. Should further studies corroborate the findings, the researchers suggest that walking pattern could become a useful and inexpensive addition to the medical toolbox for diagnosing different types of dementia. “It is a key development,” says first study author Ríona McArdle, Ph.D., of the Faculty of Medical Sciences at Newcastle University in the United Kingdom, “as a more accurate diagnosis means that we know that people are getting the right treatment, care, and management for the dementia they have.” Types and causes of dementia Dementia […]
Recent research into older adults confirms that loneliness is tied to a raised risk of developing dementia. The study also reveals that the effect ranges across a diversity of people and is independent of how much social contact they have. A large new study confirms that loneliness is a risk factor for dementia. Scientists from Florida State University (FSU) in Tallahassee used data on 12,030 individuals from the Health and Retirement Study, a United States government-sponsored longitudinal survey of a nationally representative sample of people aged 50 and older. They report their findings in a paper that now features in The Journals of Gerontology: Series B. “We are not the first people,” says first study author Dr. Angelina Sutin, who is an associate professor in FSU’s College of Medicine, “to show that loneliness is associated with increased risk of dementia.” “But this is by far the largest sample yet, with a long follow-up,” she adds. “And the population was more diverse.” The study data contained measures of loneliness and social isolation and a range of risk factors, including behavioral, clinical, and genetic. Through telephone interviews, individuals had also completed assessments of cognitive ability, a low score on which indicates dementia. […]
Latest Alzheimer’s News MONDAY, Oct. 21, 2019 (HealthDay News) — Former professional soccer players have a significantly increased risk of death from brain diseases such as Alzheimer’s and Parkinson’s, a new study finds. Former soccer players were about 3.5 times more likely to die of neurodegenerative diseases than people in the general population, according to a study in Scotland. “This analysis revealed that risk ranged from a fivefold increase in Alzheimer’s disease, through an approximately fourfold increase in motor neuron disease, to a twofold in Parkinson’s disease in former professional [soccer players] compared to population controls,” said study leader Dr. Willie Stewart. Stewart is a consultant neuropathologist and honorary clinical associate professor at the University of Glasgow. Prior studies of contact sports athletes, particularly National Football League (NFL) players in the United States, have tied repeated head blows to another degenerative brain disorder called chronic traumatic encephalopathy (CTE). Deceased Hall of Famers Frank Gifford and Junior Seau were among the NFL players who developed CTE. In one study at Boston University, risk of CTE was linked to length of time playing tackle football. “While we don’t yet know absolute risk of developing CTE among football players, this study found that […]
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
A common class of drugs that doctors prescribe for a number of conditions — from bladder problems to Parkinson’s disease and depression — may increase a person’s risk of dementia, a large new study concludes. Some common drugs may increase dementia risk. New research by scientists from the University of Nottingham in the United Kingdom has analyzed the link between a certain class of drugs and the risk of dementia. The drugs in question, called anticholinergics, work by inhibiting a chemical messenger called acetylcholine. Their effect is to help relax or contract muscles, and doctors can prescribe them to help treat bladder conditions, gastrointestinal problems, and some of the symptoms of Parkinson’s disease. In their new study, which looked at data from tens of thousands of participants, the researchers concluded that anticholinergics may increase a person’s risk of developing dementia. The National Institute for Health Research funded this study, and the scientists published their findings yesterday in JAMA Internal Medicine. An almost 50% increase in risk For their study, lead researcher Prof. Carol Coupland and team analyzed the medical records of 58,769 people with dementia and 225,574 people without dementia. They were all 55 years old or above at baseline. […]
By Adam Townsend on 09/24/2019 2:47 PM Latest Alzheimer’s News Source: MedicineNet Health News About 90% of all humans are right-handed, so what’s the deal with the other 10%? Genetics play a big role, according to a new handedness study of hundreds of thousands of Brits published this month. The findings offer more than just gee-whiz trivia; the same genes governing which hand you prefer are also implicated in schizophrenia, Parkinson’s disease and Alzheimer’s disease. The study, published in the neurology journal Brain, could be a crucial step in determining causes, risk factors and treatments for these neurological disorders. The study looked at more than 400,000 people ages 40-69 selected from the UK Biobank. The Biobank is a British nonprofit that tracks the health of more than half a million people specifically to aid medical research. Study authors looked at genotypes for participants, as well as brain image scans of about 9,000 participants and other data to determine the results. The researchers said several genes seem to generate a hand preference. Furthermore, those genes generate that preference by coding for a stronger connection between functional centers in the left and right halves of the brain. The authors concluded the genes […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Aug. 21, 2019 (HealthDay News) — Could a pacemaker for the brain improve the memories of people with dementia or Alzheimer’s disease? New research suggests it might be possible one day: Electrical stimulation directed at key memory regions of the brain created intense flashbacks in some Alzheimer’s patients, including sensations of emotions, smells, taste and temperature. In one case, a patient suddenly recalled “an entire experience of being inebriated while drinking a margarita at a resort in Aruba,” researchers said. In another, a man had a vivid flashback of feeling very full after eating sardines on his front porch two decades previously. In fact, about half of the 42 Alzheimer’s patients in the clinical trial experienced electrically induced flashbacks from decades prior, stretching back as far as the Vietnam War era, said lead researcher Dr. Wissam Deeb, an assistant professor of neurology at the University of Florida. “These memory recollections were very vivid for some people,” Deeb said. “They were associated with a lot of emotional content when patients remembered them, because they were memories they hadn’t even thought of for such a long time.” Researchers cautioned that the deep brain stimulation […]
New research that aimed to highlight the potential of new technologies to diagnose disease has suggested that virtual reality may play a crucial role in monitoring Alzheimer’s disease. VR headsets may soon serve as a better alternative to standard testing for Alzheimer’s. Dementia is a general term to describe the impairment of cognitive functions such as memory, thinking, and communication. The cognitive decline associated with dementia is progressive, and people may go through different stages. Mild cognitive impairment (MCI) is an early stage of dementia, but some people with MCI do not develop Alzheimer’s disease. MCI can result from anxiety or normal aging, so it is important to establish the cause to evaluate the risk of dementia. Alzheimer’s is the most common type of dementia. According to the World Health Organization (WHO), about 50 million people in the world have dementia. Doctors diagnose dementia in around 10 million people every year, and 60–70% of these new diagnoses detect Alzheimer’s disease. Several cognitive tests can assess dementia, but recently, researchers have been exploring the potential of new technologies to monitor the condition. A new study from Cambridge University in the United Kingdom — the results of which now appear in the […]
Research conducted in a Chinese population has found an intriguing link between the consumption of chili peppers and a heightened risk of cognitive decline. Regularly eating a lot of hot peppers may increase a person’s risk of cognitive decline. Many populations around the world add spicy peppers to their local dishes to enhance the taste and make for a more punchy culinary experience. But are spicy peppers healthful, or do they pose any health risks? The spiciest peppers in the world, such as the Carolina Reaper, could cause serious, immediate damage. For example, in 2018, a man from the United States who ate a Carolina Reaper as part of a dare in a hot pepper eating contest ended up in the emergency room with a thunderclap headache. However, most people will not reach for the extreme versions of this hot vegetable. Instead, most cuisines use much milder varieties — some of which are still very spicy — such as jalapeños, cherry peppers, cayenne peppers, Scotch bonnets, and habaneros. Previous research into the potential effects of chili peppers on health has generally had positive findings. A large cohort study from 2017, for instance, found that eating hot red chili peppers was […]
Researchers are finding new evidence that exercise — even low-intensity, casual physical activity — can boost brain health in the short- and long-term. Frequent but leisurely exercise can boost brain health. Evidence that exercise can benefit the brain and help maintain cognitive function — including memory — is accumulating. One study, for instance, suggests that engaging even in low-level phyisical activities, such as doing household chores, can help reduce the risk of cognitive impairment in older adults. Now, a team led by Michelle Voss — from the University of Iowa in Iowa City — has found evidence in support of the notion that the benefits of just one workout can predict the benefits of frequent physical activity in the long run. The team presented these findings at this year’s Cognitive Neuroscience Society’s symposia in San Francisco, CA. As symposium chair Wendy Suzuki, of New York University in New York City, explains, “There is a strong and direct link between physical activity and how your brain works.” “People still do not link physical health to brain and cognitive health; they think about fitting into a bikini or losing that last pound, not about all the brain systems they are improving and […]
(HealthDay News) — Many doctors encourage seniors to use brain fitness games as a means to help deal with dementia, Alzheimer’s and other cognitive diseases, says SeniorLiving.org. Latest Alzheimer’s News While research remains inconclusive, there appears to be a correlation between brain games and brain health. The website says brain games that may help seniors include: Memory games, such as Match and Simon. Word games, such as word searches and Scrabble. Electronic games, such as Jeopardy, Wheel of Fortune and Family Feud. Board games, such as Chess and Checkers. Interactive Wii and X-Box games. Trivia games, such as Trivial Pursuit. Copyright © 2019 HealthDay. All rights reserved. QUESTION One of the first symptoms of Alzheimer’s disease is __________________. See Answer
By Deborah DiSesa HirschHealthDay Reporter Latest Alzheimer’s News THURSDAY, Sept. 5, 2019 (HealthDay News) — Marriage has been said to deflect depression, stave off stress, even help people live longer. Now a new study says it may also decrease your chance of developing dementia. Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Married people have a far lower chance of being diagnosed with this dreaded disorder than those who are divorced or separated, widowed, or never married, according to the study. And marriage is more protective than cohabitation, the study revealed. Divorced people have more than twice the odds for mental decline compared to married folks, the 14-year study found. And divorced men have it worse: They have a 2.6 times higher chance of developing dementia than married men, while divorced women have a 30% increased risk versus married women. “There are a lot of theories about why marriage might be good for general health,” says Hui Liu, lead investigator and professor of sociology at Michigan State University. “Married people, of course, are financially better off than those who do not have a spouse,” she said. “But there are factors […]
A prescription drug already in use for the treatment of high blood pressure could be effective against conditions such as Parkinson’s, Alzheimer’s, and Huntington’s, in which toxic proteins build up in brain cells. Scientists could repurpose felodipine to prevent Parkinson’s disease. Scientists at the University of Cambridge in the United Kingdom and the Guangzhou Institutes of Biomedicine and Health in China suggest that the hypertension drug felodipine could be a promising candidate for “repurposing” as a treatment for neurodegenerative conditions. In experiments with zebrafish and mice, they showed that felodipine can prompt a cellular recycling process called autophagy to clear away toxic proteins in brain cells, or neurons. “Our data suggest,” they write in a recent Nature Communications paper, “that felodipine induces autophagy in neurons and enhances removal of a range of disease-causing proteins: mutant huntingtin, mutant [alpha]-synuclein, and tau.” Mutant huntingtin is characteristic of Huntington’s disease, while mutant alpha-synuclein and tau are hallmarks of Parkinson’s disease and Alzheimer’s disease, respectively. The study is important because it shows that felodipine can remove mutant alpha-synuclein from the brains of mice at blood levels “similar to those that would be seen in humans taking the drug [for hypertension].” “This is the first […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News MONDAY, June 17, 2019 (HealthDay News) — Treatment with blood pressure medication can improve blood flow to a key brain region in people with Alzheimer’s disease, a small clinical trial has found. Researchers stressed that they do not know whether the brain finding can translate into any benefits for patients. But future studies should look into that possibility, they said. The findings, published June 17 in the journal Hypertension, come from a trial of 44 patients with mild to moderate Alzheimer’s. They were randomly assigned to take either the blood pressure drug nilvadipine or inactive placebo pills for six months. In the end, patients on the drug showed a 20% increase in blood flow to the hippocampus — a brain structure involved in memory and learning that is one of the first areas damaged by Alzheimer’s. Experts said the study was too small and short-term to know whether the improved blood flow could have any effect on symptoms. But future research should try to answer that question and should focus on people with early Alzheimer’s, said Dr. Jurgen Claassen, the study’s lead author. The research is part of a larger trial that looked […]
For reasons as yet unknown, Alzheimer’s disease is more likely to affect women. However, new research sheds light on the potential impact of stress on their cognitive functioning. Stress during midlife can put older women at risk of Alzheimer’s disease. Alzheimer’s disease is the most common type of dementia. Affecting millions of people in the United States, this progressive condition has no proven cause, treatment, or cure. What researchers do know, however, is that women bear the brunt of the condition. Almost two-thirds of U.S. individuals with Alzheimer’s are women, according to the Alzheimer’s Association. However, only theories exist to explain this difference; there is no concrete evidence. One understudied area — say researchers at the Johns Hopkins University School of Medicine in Baltimore, MD — is the role of stress on cognitive function. Previous research has shown that age can have a significant impact on women’s stress response, and that a stressful life experience can cause memory and cognitive issues. However, these problems tend to be short term. Researchers have now decided to look at the relationship between stress and the long term cognitive decline associated with Alzheimer’s. “A normal stress response causes a temporary increase in stress hormones […]
A drug that scientists are currently developing to treat stroke survivors might also help stave off Alzheimer’s disease. Researchers are trialing a new treatment that may help people with early-stage Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia. According to the Alzheimer’s Association, 5.7 million people in the United States are living with the condition. Current medications can only relieve some symptoms of the disease, and there is not yet any way to halt its progression. The neurodegeneration that occurs in people with Alzheimer’s results from the buildup of a protein called beta-amyloid in the brain. Beta-amyloid is present in the healthy brain, but incorrectly folded proteins can accumulate to form amyloid plaques. These plaques reduce blood flow to the brain, leading to the breakdown of brain cells. Over the years, researchers have investigated many pharmacological routes to tackle these plaques, but, to date, none have led to the development of effective drugs. Recently, researchers from the University of Southern California (USC) in Los Angeles explored an innovative new compound that the scientific community is already scrutinizing. Introducing 3K3A-APC 3K3A-APC is a modified version of activated C protein, which is a blood-based protein that protects brain cells […]
It is still unclear exactly what causes Alzheimer’s disease, which is a neurodegenerative condition chiefly characterized by memory loss and other forms of cognitive impairment. However, new research is uncovering more of the factors that contribute to its pathology. According to a new study, a blood protein leaked into the brain contributes to cognitive decline. According to existing guidelines, the main mechanism associated with cognitive problems in the brains of people with Alzheimer’s disease is the formation of beta-amyloid plaques. These are buildups of toxic proteins that disrupt the normal functioning of synapses. Synapses are the connections formed between brain cells that allow information to circulate within and to and from the brain. However, in a new study from the Gladstone Institutes in San Francisco, CA, a team of researchers has identified another mechanism that affects how synapses work, contributing to Alzheimer’s pathology. The researchers began by investigating problems that appear in the blood vessel network in the brain, which is another biological characteristic of this form of dementia. Senior investigator Prof. Katerina Akassoglou and her team have for the first time identified a blood-derived protein that leaks into the brain disrupting cell-to-cell communication. The findings, which appear in the […]
A recent study has concluded that people with both higher-than-normal and lower-than-normal levels of hemoglobin have a higher risk of developing dementia as they age. A new paper looks at the link between hemoglobin and dementia risk. Hemoglobin is a protein present in red blood cells. It is responsible for carrying life giving oxygen from the lungs to the rest of the body. Low levels of hemoglobin normally signify anemia. Anemia is one of the most common blood disorders; worldwide, it affects an estimated 1.62 billion people. Low hemoglobin levels are linked to a number of adverse health outcomes, including stroke and coronary heart disease. However, there is little information regarding how hemoglobin levels might relate to the risk of dementia. Anemia and dementia Recently, researchers from the Erasmus Medical Center in Rotterdam, the Netherlands, decided to look for links between hemoglobin levels, anemia, and dementia. They published their findings this week in the journal Neurology. Earlier experiments had found an association between anemia and dementia, but most studies only followed participants for an average of 3 years. Because of the relatively short duration of these investigations, subtle changes in behavior, diet, or metabolism during the early phases of dementia […]
Latest Alzheimer’s News WEDNESDAY, Sept. 11, 2019 (HealthDay News) — Sleep loss is a problem for people who care for loved ones with dementia, which can put both caregivers and patients at risk, researchers say. Investigators at Baylor University in Waco, Texas, found caregivers lost between 2.5 to 3.5 hours of sleep a week due to difficulty falling asleep and staying asleep. “Losing 3.5 hours of sleep per week does not seem much, but caregivers often experience accumulation of sleep loss over years,” said review lead author Chenlu Gao, a doctoral candidate of psychology and neuroscience. “Losing 3.5 hours of sleep weekly on top of all the stress, grief and sadness can have a really strong impact on caregivers’ cognition, and mental and physical health,” Gao added in a university news release. But improving caregivers’ sleep quality can significantly improve their functioning and quality of life, Gao said. For example, the researchers found that caregivers’ sleep noticeably improved after simple changes such as getting more morning sunlight, establishing a regular and relaxing bedtime routine, and doing moderate physical exercise. Chronic stress can cause sleep problems, and nighttime awakenings by people with dementia can also disrupt caregivers’ sleep, the researchers noted. […]
As scientists delve deeper into the nature of Parkinson’s, the more it appears that it is highly varied, suggesting numerous subtypes. A new review proposes that Parkinson’s falls into one of two main categories, depending on whether it originates in the central nervous system (CNS) or the peripheral nervous system (PNS). Share on PinterestNew research redefines Parkinson’s disease. In a recent Journal of Parkinson’s Disease paper, scientists from Denmark argue how results from imaging and tissue studies fit with a theory of Parkinson’s that divides the condition “into a PNS-first and a CNS-first subtype.” Parkinson’s disease principally destroys dopamine cells in the brain’s substantia nigra area. This is the part that controls movement. This damage gives rise to the most common symptoms, including tremors, rigidity, and balance difficulties. Parkinson’s disease may also cause emotional changes, depression, constipation, sleep disruption, and urinary problems. The pattern of symptoms and their rate of progression can vary widely among individuals. A distinguishing feature of Parkinson’s, however, is the accumulation and spread of toxic clumps of alpha-synuclein protein called Lewy bodies. These clumps are also hallmarks of dementia with Lewy bodies. Debating the origins of Parkinson’s Some scientists have proposed that the toxic alpha-synuclein forms […]
According to a team of Swedish-based researchers, breathing through the nose may help memory storage and consolidation. These findings are published in The Journal of Neuroscience. The way we breathe affects our memory in mysterious ways. Recently, neuroscientists have been scrutinizing the link between smell and memory. Some have suggested that a damaged sense of smell can predict dementia, and others have zoomed in on why that may be. Along the way to unraveling the Proustian mysteries of smells and memory, scientists have picked up several clues. The amygdala, which is a small brain region that processes sensory information, is close to the memory-storing hippocampus. Also, newer research shows that people with a good spatial memory may be better at identifying smells. Information related to time and space is present in the anterior olfactory nucleus, studies have shown. This is a brain area that is involved in the development of Alzheimer’s. New research now adds breathing into the mix. A study carried out by scientists at the Karolinska Institutet in Stockholm, Sweden, finds that breathing through the nose, rather than the mouth, improves olfactory memory. Artin Arshamian, a researcher at the Department of Clinical Neuroscience with the Karolinska Institutet, is […]
For the first time, a new study has observed that cerebrospinal fluid washes in and out of the brain in waves during sleep, helping clear out waste. Cerebrospinal fluid helps clear toxic waste from the brain during sleep. Recently, Medical News Today reported on a study that found that specialized immune cells are more active in the brain during sleep, busy performing maintenance work. Researchers know that sleep is important — not just in terms of allowing the brain to reactualize, but also for “making space” for “cleaning” processes to take place. However, many of the mechanisms through which this clearing out of brain waste takes place during sleep remain unclear. Now, researchers at Boston University in Massachusetts have found that during sleep, the fluid present in the brain and spinal chord — called the cerebrospinal fluid — washes in and out, like waves, helping the brain get rid of accumulated metabolic “trash.” “We’ve known for a while that there are these electrical waves of activity in the neurons. But before now, we didn’t realize that there are actually waves in the cerebrospinal fluid, too,” study co-author Laura Lewis explains. A complex synchronization process The new study — the results […]
(HealthDay News) — Dementia is a group of symptoms associated with a decline in memory or thinking skills. Latest Alzheimer’s News Because the progression of dementia varies, deciding when a person is no longer able to drive safely can be difficult, says the National Center on Caregiving. For caregivers and those who have a loved one with dementia, the center suggests: If the person has mild dementia, have driving skills evaluated immediately. If the person with dementia passes, continue to have driving skills evaluated every 6 months. Watch for behavioral signs, such as disorientation and difficulty processing. Watch for poor driving behavior, such as drifting or incorrect signaling. Encourage the person to drive on familiar roads, and avoid nighttime driving. The NCC also suggests reducing the need to drive by arranging alternative transportation. Copyright © 2019 HealthDay. All rights reserved. SLIDESHOW Dementia, Alzheimer’s Disease, and Aging Brains See Slideshow
A new study finds that people with Alzheimer’s disease who also took antidiabetes medication exhibited fewer molecular markers of the neurological condition. These findings could inform future Alzheimer’s treatments. A study examined the molecular pathways of brain tissue and the cells that line the inside of blood vessels in the brains of people with Alzheimer’s and diabetes. New research — led by Vahram Haroutunian, Ph.D., a professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai in New York City, NY — analyzed the brain tissues of people who had both Alzheimer’s disease and diabetes. The findings suggest that antidiabetes drugs may protect the brain against Alzheimer’s. As Prof. Haroutunian and colleagues explain in their paper, a mounting body of evidence has been pointing to a link between the risk of mild cognitive impairment, dementia, and type 2 diabetes. Additional studies have uncovered an association between an insulin receptor pathway in the brain and the accumulation of Alzheimer’s-specific brain pathologies. Previous studies conducted by the same Prof. Haroutunian and colleagues found that the brains of people with Alzheimer’s who had also undergone treatment for diabetes, such as insulin or antidiabetes medicine, had reduced brain pathologies. So, […]
A recent study concludes that social interaction might be more than just a pleasant pastime; it might help doctors predict an individual’s risk of cognitive decline and, perhaps, dementia. How does social interaction influence cognitive decline? Cognitive decline refers to a general reduction in mental abilities over time. It affects many people as they age and, in some cases, can lead to dementia. As the average age of the population rises, an increasing number of people are likely to experience cognitive decline. A group of researchers from Brigham and Women’s Hospital in Boston, MA, are interested in the potential role that social interaction might play. Specifically, their most recent study looked at whether there is an interaction between levels of social activity, cognitive performance, and the amount of beta-amyloid in the brain, which is a neurological hallmark of Alzheimer’s disease. Cognitive decline and sociability To investigate, the scientists followed 217 older adults involved in the Harvard Aging Brain Study. At the beginning of the study, participants were aged 63–89 and showed no cognitive deficits. The authors followed the group for 3 years. Each participant completed a questionnaire that ascertained their levels of social interaction; this included meeting family and friends, […]
close
The information contained within this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Members contribute personal experiences by sharing what did or didn’t work to address their concern and help educate others which may expedite recovery. As such, always seek the advice of your physician or other qualified health provider with any questions about your medical condition. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish
Recent Comments